	Human papilloma virus
HPV 6 and 11
Vaccination
Recurrent respiratory papillomatosis
	laryngeal papillomas
HPV
early proteins E
infection
disease
papillomas
children
benign tumours
Large multi-centre collaborative clinical trials
sufficient clinical follow-up data
prophylactic HPV vaccines
small nonenveloped viruses
infected host cells
mumps vaccine
virus
sufficient
RRP
surgical
HPV types
evidence
risk factors
juvenile onset form
adequate airway
low incidence
adult form
proteins
treatment
cells
years
risk
cidofovir
forms
lesions
genome

